233 related articles for article (PubMed ID: 10093577)
1. [Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide].
Rischke HC; Staib-Sebler E; Mose S; Adams SW; Herrmann G; Böttcher HD; Lorenz M
Dtsch Med Wochenschr; 1999 Feb; 124(7):182-6. PubMed ID: 10093577
[TBL] [Abstract][Full Text] [Related]
2. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Rai Y; Emi Y; Nishijima N; Kai S; Kano T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
[TBL] [Abstract][Full Text] [Related]
3. Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration.
McIntire M; Siziopikou K; Patil J; Gattuso P
Diagn Cytopathol; 2008 Jan; 36(1):54-7. PubMed ID: 18064696
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.
di Bartolomeo M; Bajetta E; Buzzoni R; Mariani L; Carnaghi C; Somma L; Zilembo N; di Leo A
Cancer; 1996 Jan; 77(2):402-8. PubMed ID: 8625251
[TBL] [Abstract][Full Text] [Related]
6. [An elderly woman with breast cancer and multiple liver metastasis that responded well to combination therapy of fadrozole and tamoxifen].
Nakajima Y; Hirayama K; Saitoh K; Terashima H; Shimada T; Nishiyama S; Shimizu T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2065-8. PubMed ID: 11791386
[TBL] [Abstract][Full Text] [Related]
7. Large-cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighteen cases and the efficacy of adjuvant treatment with octreotide.
Filosso PL; Ruffini E; Oliaro A; Rena O; Casadio C; Mancuso M; Turello D; Cristofori RC; Maggi G
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):819-24. PubMed ID: 15821649
[TBL] [Abstract][Full Text] [Related]
8. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
9. [Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
Akiyama S; Niitani T; Narasaka T; Ohto T; Gamoh M
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1209-12. PubMed ID: 21772114
[TBL] [Abstract][Full Text] [Related]
10. Metastatic breast neuroendocrine tumor from the rectum.
Al-Maghrabi JA; Zekri J
Saudi Med J; 2012 Jun; 33(6):676-9. PubMed ID: 22729125
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
12. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].
Rai Y; Sagara Y; Sagara Y; Ooi Y
Gan To Kagaku Ryoho; 2004 Mar; 31(3):443-7. PubMed ID: 15045959
[TBL] [Abstract][Full Text] [Related]
14. A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.
Bajetta E; Procopio G; Ferrari L; Martinetti A; Zilembo N; Catena L; Alú M; Della TS; Alberti D; Buzzoni R
Cancer; 2002 Jan; 94(2):299-304. PubMed ID: 11900215
[TBL] [Abstract][Full Text] [Related]
15. The surgical and systemic management of neuroendocrine tumors of the pancreas.
Abood GJ; Go A; Malhotra D; Shoup M
Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239
[TBL] [Abstract][Full Text] [Related]
16. [Hormone therapy of postoperative recurrent pancreatic carcinoma with octreotide and tamoxifen].
Wenger FA; Zieren HU; Jacobi CA; Müller JM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1348-50. PubMed ID: 9931878
[TBL] [Abstract][Full Text] [Related]
17. [W.D.H.A. Syndrome due to occult neuroendocrine malignancy with concomitant liver metastases].
Rammer M; Kirchgatterer A; Höbling W; Stockhammer M; Knoflach P
Z Gastroenterol; 2003 Feb; 41(2):185-9. PubMed ID: 12592602
[TBL] [Abstract][Full Text] [Related]
18. Does hormonal therapy have a therapeutic role in metastatic primary small cell neuroendocrine breast carcinoma? Case report and literature review.
Alkaied H; Harris K; Brenner A; Awasum M; Varma S
Clin Breast Cancer; 2012 Jun; 12(3):226-30. PubMed ID: 22424945
[TBL] [Abstract][Full Text] [Related]
19. [Asymptomatic multinodular liver disease].
Cadiot G
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B154-8. PubMed ID: 12843952
[No Abstract] [Full Text] [Related]
20. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
